Research progress of lymphadenectomy for thoracic esophageal cancer

doi:10.3877/cma.j.issn.2095-8773.2015.04.002

Abstract

Abstract:

There have been many controversies about the optimal extent of lymphadenectomy for thoracic esophageal cancer, especially on whether three-field lymphadenectomy is superior to two-field lymphadenectomy with respect to the 5-year survival rate and perioperative morbidities and mortality. Published evidence indicated that three-field lymphadenectomy could be a priority for thoracic esophageal cancer, especially for tumors with lymph node metastasis. Given the lack of large-sample randomized controlled studies, further evaluations are necessary. Salvage cervical lymphadenectomy might be the main treatment for esophageal carcinoma patients who develop recurrence in the cervical lymph node after curative esophagectomy; however, more prospective studies are warranted in future. In this review, we focus on two aspects of controversy about the optimal extent of lymphadenectomy for thoracic esophageal cancer and significance of salvage cervical lymphadenectomy in the treatment of patients who develop recurrence in the cervical lymph node after curative esophagectomy.

Key words: Esophageal cancer, Lymphadenectomy, Salvage cervical lymphadenectomy

Xiankai Chen, Yin Li, Haibo Sun. Research progress of lymphadenectomy for thoracic esophageal cancer[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2015, 02(04): 218-221.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxbwkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8773.2015.04.002

https://zhxbwkdzzz.cma-cmc.com.cn/EN/Y2015/V02/I04/218

References 23

[1]	Tanaka T, Matono S, Nagano T, et al. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors[J]. Ann Surg Oncol, 2012, 19(3): 750-756.
[2]	郭昭扬. 胸段食管癌颈部及上纵隔淋巴结转移[J]. 中华胸心血管外科杂志，1999, 1(15)：18-19.
[3]	Gockel I, Sgourakis G, Lyros O, et al. Dissection of lymph node metastases in esophageal cancer[J]. Expert Rev Anticancer Ther, 2011, 11(4): 571-578.
[4]	冯键，方文涛. 胸段食管癌三野淋巴结清扫现状[J]. 医学临床研究，2008, 25(10): 1893-1896.
[5]	Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.[J] Ann Surg, 2004, 240(6): 962-972; discussion 972-964.
[6]	Fujita H, Sueyoshi S, Tanaka T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy[J]. World J Surg, 2003, 27(5): 571-579.
[7]	王旭广，毛志福，师晓天，等. 胸段食管鳞癌淋巴结合理廓清范围的探讨[J]. 中国胸心血管外科临床杂志，2005, 12(2): 136-138.
[8]	张亚伟，胡鸿，缪珑升，等. 胸中段食管癌淋巴结二野清扫术和三野清扫术的比较[J]. 中国癌症杂志，2008, 18(7): 537-541.
[9]	Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1，000 consecutive resections at a single center in the Western world[J]. Ann Surg, 2001, 234(3): 360-367; discussion 368-369.
[10]	毛友生，赫捷，程贵余. 我国食管癌外科治疗的现状与未来对策[J]. 中华肿瘤杂志，2010, 32(6): 401-404.
[11]	邵令方，高宗人，卫功铨，等. 食管癌和贲门癌的外科治疗[J]. 中华外科杂志，2001, 39(1): 44-46.
[12]	柳硕岩，佘志廉，朱坤寿. 472例胸段食管癌行颈、胸、腹三野淋巴结清扫术的临床研究[J]. 福建医药杂志，2005, 6(27)：38-40.
[13]	Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus[J]. Ann Surg, 1994, 220(3): 364-372; discussion 372-363.
[14]	Fujita H, Kakegawa T, Yamana H, et al. Cervico-thoraco-abdominal (3-field) lymph node dissection for carcinoma in the thoracic esophagus[J]. Kurume Med J, 1992, 39(3): 167-174.
[15]	Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy[J]. Ann Surg, 1995, 222(5): 654-662.
[16]	Kato H, Watanabe H, Tachimori Y, et al. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma[J]. Ann Thorac Surg, 1991, 51(6): 931-935.
[17]	Shim YM, Kim HK, Kim K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma[J]. J Thorac Oncol, 2010, 5(5): 707-712.
[18]	佘志廉. 食管癌颈胸腹淋巴结清扫研究[J]．中国肿瘤，2001, 3(10)：148-149.
[19]	Tabira Y, Kitamura N, Yoshioka M, et al. Significance of three-field lymphadenectomy for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph nodal involvement and survival rate[J]. J Cardiovasc Surg (Torino), 1999, 40(5): 737-740.
[20]	Shiozaki H, Yano M, Tsujinaka T, et al. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer[J]. Dis Esophagus, 2001, 14(3-4): 191-196.
[21]	Ma X, Zhao K, Guo W, et al. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma[J]. Ann Surg Oncol, 2015，22(2)：624-629.
[22]	Kato H, Fukuchi M, Miyazaki T, et al. Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy[J]. Anticancer Res, 2005, 25(5): 3461-3467.
[23]	Hiyoshi Y, Morita M, Kawano H, et al. Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy[J]. Ann Surg Oncol, 2014，22(1)：240-246.

Please choose a citation manager

Content to export